MOH
- Status: likely_approved
Skytrofa (LONAPEGSOMATROPIN) regulatory status in United Arab Emirates.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH has authorised it; MOH has authorised it.
Ascendis Pharma Encocrinology Div A/S is the originator. The local marketing authorisation holder may differ — check the official source linked above.